EMERYVILLE, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. today announced that it will webcast a teleconference with management to discuss third quarter 2005 financial results and provide a general business overview, including a summary of recent clinical data. The teleconference is scheduled for Thursday, November 3, 2005, at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time). Financial results for the third quarter ended September 30, 2005 will be released on Wednesday, November 2, 2005.
Interested parties may access a live webcast of the presentation at: http://audioevent.mshow.com/258027/
or by dialing 706-758-9355 and using the conference ID 1669395. A replay of the presentation will be available on the Onyx website or by dialing 706-645-9291 and using the conference ID 1669395 approximately two hours after the teleconference concludes. The replay will be available through December 3, 2005.
Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including sorafenib with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at www.onyx-pharm.com.
Onyx PharmaceuticalsCONTACT: Julie Wood, +1-510-597-6505, or Alex Santos, +1-510-597-6504
Web site: http://www.onyx-pharm.com/
